Could everyday supplements ease a rare lung disease?
NCT ID NCT06567717
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether a combination of zinc and nicotinamide riboside can help people with idiopathic pulmonary fibrosis (IPF) feel better and breathe easier. Sixty participants will take the supplements or a placebo twice a day for 24 weeks, all from home with remote check-ins. The main goal is to see if this home-based approach works for future trials, while also checking for any symptom improvement.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
zinc and nicotinamide riboside
What this could lead to
If it works, this could point toward a simple supplement-based way to improve symptoms and quality of life for people with IPF.
What could go wrong
This is a small, early-phase trial focused on feasibility, not yet on proving effectiveness. The supplements may not improve lung function or symptoms, and side effects are possible.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for IDIOPATHIC PULMONARY FIBROSIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Cedars-Sinai
RECRUITINGLos Angeles, California, 90048, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••